Genomics Company Illumigen Biosciences, Inc. Completes $12 Million Recap Round

4/28/2006 11:39:50 AM

4/28/2006 – Hoping to harness the properties of beneficial genetic mutations for new therapies, Illumigen Biosciences Inc. closed a $12 million recapitalization, which includes about $8 million in new money, VentureWire has learned.

Read at VentureReporter.net [Registration Required]

Read Article at

Related Companies

News Categories

• VentureReporter.net [Registration Required]

• Illumigen Biosciences, Inc.

• Biotech/Pharma - Gene Discovery

• Biotech/Pharma - Investor

• Biotech/Pharma - Finance, Start-Up